Surface Oncology closes $11.5mm PIPE concurrent with IPO

15:40 EDT 20 Apr 2018 | Elsevier Business Intelligence

Surface Oncology Inc. (cancer immunotherapies) grossed $11.5mm through a private placement of 766,666 common shares at $15 ap...

Original Article: Surface Oncology closes $11.5mm PIPE concurrent with IPO

More From BioPortfolio on "Surface Oncology closes $11.5mm PIPE concurrent with IPO"